Report Screener | Stock Screener | Bond Screener | Fund Screener

Report Search Results As of 24-Apr-2014
New Screen 

All Reports | Brokerage Reports | Independent Reports
All Reports (Showing 1 to 10 of 22)
Release
Date
 [down]
Contributor Author Title Pages Price StarMine Author Rating More Info
EPS Accuracy * Portfolio Return **
24-Apr-14ValuEngine, Inc.N/AValuEngine Industry Report for Medical-drugs18$49  View Abstract
24-Apr-14New Constructs, LLCN/APIP: Due Diligence Review: Forensic Earnings and Valuation5$25  View Abstract
23-Apr-14Thomson Reuters Stock ReportN/AThomson Reuters Stock Report - PHARMATHENE INC. (PIP-A)11$25  View Abstract
23-Apr-14Thomson Reuters Stock ReportN/AThomson Reuters Stock Report - PEPSI-COLA PRODUCTS PHILIPPINES INC (PIP-PH)11$25  View Abstract
21-Apr-14GlobalDataGlobalDataPharmAthene, Inc. (PIP) - Pharmaceuticals & Healthcare - Deals and Alliances Profile31$250  View Abstract
19-Apr-14Reuters Investment ProfileN/APepsi Cola Products Philippines Inc: Business description, financial summary, 3yr and interim financials, key statistics/ratios and historical ratio analysis.12$138  View Abstract
19-Apr-14Reuters Investment ProfileN/APipe Works L Girakian Profil SA: Business description, financial summary, 3yr and interim financials, key statistics/ratios and historical ratio analysis.12$138  View Abstract
19-Apr-14Wright ReportsN/AWright Investors Service Comprehensive Report for Pharmathene Inc.40$75  View Abstract
19-Apr-14Pechala's ReportsFrantisek PechalaPHARMATHENE INC (PIP) 12-months forecast1$15  View Abstract
19-Apr-14Reuters Investment ProfileN/APharmAthene Inc: Business description, financial summary, 3yr and interim financials, key statistics/ratios and historical ratio analysis.12$138  View Abstract
Next 12

Independent Reports (Showing 1 to 10 of 22)
Release
Date
 [down]
Contributor Author Title Pages Price More Info
24-Apr-14ValuEngine, Inc.N/AValuEngine Industry Report for Medical-drugs18$49View Abstract
24-Apr-14New Constructs, LLCN/APIP: Due Diligence Review: Forensic Earnings and Valuation5$25View Abstract
23-Apr-14Thomson Reuters Stock ReportN/AThomson Reuters Stock Report - PHARMATHENE INC. (PIP-A)11$25View Abstract
23-Apr-14Thomson Reuters Stock ReportN/AThomson Reuters Stock Report - PEPSI-COLA PRODUCTS PHILIPPINES INC (PIP-PH)11$25View Abstract
21-Apr-14GlobalDataGlobalDataPharmAthene, Inc. (PIP) - Pharmaceuticals & Healthcare - Deals and Alliances Profile31$250View Abstract
19-Apr-14Reuters Investment ProfileN/APepsi Cola Products Philippines Inc: Business description, financial summary, 3yr and interim financials, key statistics/ratios and historical ratio analysis.12$138View Abstract
19-Apr-14Reuters Investment ProfileN/APipe Works L Girakian Profil SA: Business description, financial summary, 3yr and interim financials, key statistics/ratios and historical ratio analysis.12$138View Abstract
19-Apr-14Wright ReportsN/AWright Investors Service Comprehensive Report for Pharmathene Inc.40$75View Abstract
19-Apr-14Pechala's ReportsFrantisek PechalaPHARMATHENE INC (PIP) 12-months forecast1$15View Abstract
19-Apr-14Reuters Investment ProfileN/APharmAthene Inc: Business description, financial summary, 3yr and interim financials, key statistics/ratios and historical ratio analysis.12$138View Abstract
Next 12

* EPS Accuracy is a measure of an analyst's ability to accurately estimate the EPS for a company.
** Portfolio Return is a measure of the performance of an analyst's recommendations relative to his peers.


Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Yahoo nor any of its data or content providers shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon.